BIOMAT Database Logo BIOMAT Database Logo

Comparison of in vitro dissolution and in vivo bioavailability of methaqualone tablets in humans. 1978

R G Stoll, and G C Chao, and H J Hoyt, and A Yacobi

Two methaqualone tablets that exhibited different in vitro dissolution rates were administered to 11 normal healthy male volunteers. Serial blood samples were withdrawn following administration of each tablet, and plasma methaqualone concentrations were determined by an established spectrophotofluormetric assay. Both tablets produced virtually identical plasma concentration versus time profiles in humans, and no statistically significant differences in either the rate or extent of drug absorbed were detected. The results indicate that there is no correlation between in vivo bioavailability and the modified NF in vitro dissolution test used.

UI MeSH Term Description Entries
D008297 Male Males
D008702 Methaqualone A quinazoline derivative with hypnotic and sedative properties. It has been withdrawn from the market in many countries because of problems with abuse. (From Martindale, The Extra Pharmacopoeia, 30th ed, p604) Metolquizolone,Ortonal,Methaqualone Hydrochloride,Optimil,Quaalude,Hydrochloride, Methaqualone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet

Related Publications

R G Stoll, and G C Chao, and H J Hoyt, and A Yacobi
Bioavailability of Nalidixic acid from uncoated tablets in humans--Part II: Bioavailability in beagles and its correlation with bioavailability in humans and in vitro dissolution rates.
May 1984, International journal of clinical pharmacology, therapy, and toxicology,
R G Stoll, and G C Chao, and H J Hoyt, and A Yacobi
Bioavailability of pyridoxal phosphate from enteric-coated tablets. III. Correlations between bioavailability in humans and beagle dogs and between bioavailability in humans and in vitro dissolution rates.
September 1985, Chemical & pharmaceutical bulletin,
R G Stoll, and G C Chao, and H J Hoyt, and A Yacobi
Dissolution of calcium fluoride tablets in vitro and bioavailability in man.
April 1987, Scandinavian journal of dental research,
R G Stoll, and G C Chao, and H J Hoyt, and A Yacobi
Correlations between in vitro dissolution rate and bioavailability of alaproclate tablets.
August 1984, Journal of pharmacokinetics and biopharmaceutics,
R G Stoll, and G C Chao, and H J Hoyt, and A Yacobi
Bioavailability of tolazamide from tablets: comparison of in vitro and in vivo results.
November 1982, Journal of pharmaceutical sciences,
R G Stoll, and G C Chao, and H J Hoyt, and A Yacobi
Dissolution and bioavailability of digoxin tablets.
December 1973, The Journal of pharmacy and pharmacology,
R G Stoll, and G C Chao, and H J Hoyt, and A Yacobi
Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates.
July 2009, Pakistan journal of pharmaceutical sciences,
R G Stoll, and G C Chao, and H J Hoyt, and A Yacobi
Bioavailability of griseofulvin from tablets in beagle dogs and correlation with dissolution rate and bioavailability in humans.
October 1982, Journal of pharmaceutical sciences,
R G Stoll, and G C Chao, and H J Hoyt, and A Yacobi
In vitro dissolution and in vivo bioavailability of commercial levothyroxine sodium tablets in the hypothyroid dog model.
February 1990, Journal of pharmaceutical sciences,
R G Stoll, and G C Chao, and H J Hoyt, and A Yacobi
Bioavailability of digoxin tablets in relation to their dissolution in vitro.
July 1975, Journal of pharmaceutical sciences,
Copied contents to your clipboard!